Pharma Journalist 8791 posts 0 comments

Merck, known as MSD outside the United States and Canada, announced that the European Commission (EC) has approved KEYTRUDA, Merck’s anti-PD-1 therapy, in combination with chemotherapy…
Read More...

INOVIO a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases, cancer, and HPV-associated diseases,…
Read More...

SMi Reports: Registration is open for SM’s inaugural conference: Transdermal and Microneedle Delivery will take place on 24th - 25th January 2022 SMi Group is proud to present the…
Read More...

Mablink Bioscience S.A.S. a biotechnology company developing a pipeline of ADC based on its proprietary PSARlink™ drug-linker technology and Emergence Therapeutics AG, a European…
Read More...

Atreca, Inc. a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human…
Read More...

Pfizer Inc. and BioNTech SE announced topline results from a Phase 3 randomized, controlled trial evaluating the efficacy and safety of a 30-µg booster dose of the Pfizer-BioNTech…
Read More...

Oncodesign, a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine, and TiumBio a company specializing in R&D for rare diseases, have…
Read More...

SMi Reports: Registration is open for SMi’s 14th Annual Conference and Exhibition taking place between 12th-13th January 2022 in London, UK. The pre-filled syringes industry is…
Read More...

Biotage AB (publ) has entered into an agreement to acquire all outstanding shares in the privately held company ATDBio Limited based in Oxford and Southampton, UK, for a total purchase…
Read More...

BeiGene, a global, science-driven biotechnology company focused on developing innovative and affordable medicines to improve treatment outcomes and access for patients worldwide, and…
Read More...